SRPK1 and osteosarcoma: The findings that miR-659-3p targeted SRPK1 3’UTR, negatively regulated SRPK1 expression, and regulated osteosarcoma cell proliferation lead us to further explore the hypothesis that miR-659-3p affects osteosarcoma cell cycle progression through SRPK1.